Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats

Journal of Anatomy

Volumn 222, Issue 2, 2013, Pages 239-247

  Longhini, Renata ^a   de Oliveira, Priscila Aparecida ^a   de Souza Faloni, Ana Paula ^a   Sasso Cerri, Estela ^a,b   Cerri, Paulo Sérgio ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alveolar bone; Apoptosis; Cimetidine; Osteoclast; Osteoclastogenesis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CASPASE 3; CIMETIDINE; HYCIMET; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DEMINERALIZATION; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MAXILLA; MOLAR TOOTH; NICK END LABELING; NONHUMAN; OSTEOCLAST; PERIODONTIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION;

ANIMALS; APOPTOSIS; CIMETIDINE; HISTAMINE H2 ANTAGONISTS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OSTEOCLASTS; PERIODONTIUM; RANK LIGAND; RATS;

RATTUS;

EID: 84872667594     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/joa.12011     Document Type: Article

References (47)

1. 2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric ulcer. Ter Arkh 71, 23-26.
2. Biosse-Duplan M, Baroukh B, Dy M, et al. (2009) Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol 174, 1426-1434.
3. Blumer JFM, Hausott B, Schwazer C, et al. (2012) Role of tartrate-resistant acid phosphatase (TRAP) in long bone development. Mech Dev 129, 162-176.
4. Brandes LJ, LaBella FS, Glavin GB, et al. (1990) Histamine as an intracellular messenger. Biochem Pharmacol 40, 1677-1681.
5. ® (tacrolimus) induces histopathological disorders in the peritubular tissue of rat testes. Cells Tissues Organs 194, 421-430.
6. Cerri PS (2005) Osteoblasts engulf apoptotic bodies during alveolar bone formation in the rat maxilla. Anat Rec 286, 833-840.
7. Cerri PS, Freymüller E, Katchburian E (2000) Apoptosis in the early developing periodontium of rat molars. Anat Rec 258, 136-144.
8. Cerri PS, Boabaid F, Katchburian E (2003) Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats. J Periodontal Res 38, 223-226.
9. Cerri PS, Pereira-Júnior JA, Barrionuevo NB, et al. (2010) Mast cells and MMP-9 in the lamina propria during eruption of rat molars: quantitative and immunohistochemical evaluation. J Anat 217, 116-125.
10. Crisp AJ, Wright JK, Hazleman BL (1986) Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. Ann Rheum Dis 45, 422-427.
11. Cruzoé-Souza M, Sasso-Cerri E, Cerri PS (2009) Immunohistochemical detection of estrogen receptor β in alveolar bone cells of estradiol-treated female rats: possible direct action of estrogen on osteoclast life span. J Anat 215, 673-681.
12. Deyama Y, Kikuiri T, Ohnishi G, et al. (2002) Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB ligand by osteoblasts. Biochem Biophys Res Commun 298, 240-246.
13. 2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 173, 10-18.
14. Faloni APS, Sasso-Cerri E, Katchburian E, et al. (2007) Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats. J Periodontal Res 42, 193-201.
15. Faloni AP, Sasso-Cerri E, Rocha FR, et al. (2012) Structural and functional changes in the alveolar bone osteoclasts of estrogen-treated rats. J Anat 220, 77-85.
16. Garant PR (2003) Bone. In: Oral Cells and Tissues, pp. 195-238. Illinois, USA: Quintessence Publishing.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119, 493-501.
18. Glantschnig H, Fischer JE, Wesolowski G, et al. (2003) M-CSF, TNF-α and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10, 1165-1177.
19. Gonçalves JS, Sasso-Cerri E, Cerri PS (2008) Cell death and quantitative reduction of rests of Malassez according to age. J Periodontal Res 43, 478-481.
20. Hall TJ, Schaueblin M (1994) Promethazine inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int 55, 68-70.
21. 2 antagonist prevents periodontitis in a rabbit model. Infect Immun 74, 2402-2414.
22. Hill SJ, Ganellin CR, Timmerman H, et al. (1997) International Union of Pharmacology XIII. Classification of histamine receptors. Pharmacol Rev 49, 253-278.
23. Huppertz B, Frank HG, Kaufmann P (1999) The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 200, 1-18.
24. Ikawa Y, Yonekawa T, Ohkuni Y, et al. (2007) A comparative study of histamine activities on differentiation of osteoblast and osteoclast. J Toxicol Sci 32, 555-564.
25. Ito M, Amizuka N, Nakajima T, et al. (2001) Bisphosphonate acts on osteoclasts independent of ruffled borders in osteoclerotic (oc/oc) mice. Bone 28, 609-616.
26. Jilka RL, Takahashi K, Munshi M, et al. (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. J Clin Invest 101, 1942-1950.
27. 2 receptors. Nature 413, 420-425.
28. LaBella FS, Brandes LJ (2000) Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs. Semin Cancer Biol 10, 47-53.
29. 2 receptor antagonist cimetidine. Bone 30, 131-136.
30. Leclous P, Guez D, Baroukh B, et al. (2004) Histamine participates in the early phase of trabecular bone loss in ovariectomized rats. Bone 34, 91-99.
31. Lesclous PH, Schramm F, Gallina S, et al. (2006) Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats. Exp Physiol 91, 561-570.
32. Lockshin RA, Zakeri Z (2004) Apoptosis, autophagy, and more. Int J Biochem Cell Biol 36, 2405-2419.
33. Mor S, Nagler A, Barak V, et al. (1995) Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin production by human peripheral blood mononuclear cells. J Leukoc Biol 58, 445-450.
34. Nakamura M, Kuroda H, Namita K, et al. (1996) Parathyroid hormone induces a rapid increase in the number of active osteoclast by releasing histamine from mast cell. Life Sci 58, 1861-1868.
35. Nanci A, Bosshardt DD (2006) Structure of periodontal tissues in health and disease. Periodontol 2000(40), 11-28.
36. Phan TCA, Xu J, Zheng MH (2004) Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol 19, 1325-1344.
37. Raff M (1998) Cell suicide for beginners. Nature 396, 119-122.
38. Riggs BL (2000) The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106, 1203-1204.
39. Schneider E, Rolli-Derkinderen M, Arock M, et al. (2002) Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23, 255-263.
40. 3 receptors: stimulation of IL-10 production. J Immunol 164, 2964-2970.
41. Sodek J, Mckee MD (2000) Molecular and cellular biology of alveolar bone. Periodontol 2000(24), 99-126.
42. Takamatsu S, Nakano K (1998) Regulation of interleukin-6, and macrophage colony-stimulating factor mRNA levels by histamine in stromal cell line (MC3T3-GP/PA6). Inflamm Res 47, 221-226.
43. 2 receptors in peripheral blood mononuclear cells. J Biol Chem 269, 9952-9956.
44. Wu X, McKenna MA, Feng X, et al. (2003) Osteoclast apoptosis: the role of Fas in vivo and in vitro. Endocrinology 144, 5545-5555.
45. Wu X, Ahn EY, McKenna MA, et al. (2005) Fas binding to calmodulin regulates apoptosis in osteoclasts. J Biol Chem 280, 29964-29970.
46. 2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. J Pharmacol Sci 92, 43-49.
47. Yasuda H, Shima N, Nakagawa N, et al. (1999) A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25, 109-113.